Literature DB >> 33759006

Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?

Patrick M Honore1, Sebastien Redant2, David De Bels2.   

Abstract

Entities:  

Year:  2021        PMID： 33759006     DOI： 10.1186/s40635-021-00376-w

Source DB:  PubMed          Journal:  Intensive Care Med Exp        ISSN： 2197-425X


× No keyword cloud information.
  4 in total

1.  The wind changed direction and the big river still flows: from EUPHRATES to TIGRIS.

Authors:  Toshiaki Iba; David J Klein
Journal:  J Intensive Care       Date:  2019-05-16

2.  Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.

Authors:  D J Klein; D Foster; P M Walker; S M Bagshaw; H Mekonnen; M Antonelli
Journal:  Intensive Care Med       Date:  2018-11-23       Impact factor: 17.440

3.  Endotoxemia and circulating bacteriome in severe COVID-19 patients.

Authors:  Phatadon Sirivongrangson; Win Kulvichit; Sunchai Payungporn; Trairak Pisitkun; Ariya Chindamporn; Sadudee Peerapornratana; Prapaporn Pisitkun; Suwalak Chitcharoen; Vorthon Sawaswong; Navaporn Worasilchai; Sarinya Kampunya; Opass Putcharoen; Thammasak Thawitsri; Nophol Leelayuwatanakul; Napplika Kongpolprom; Vorakamol Phoophiboon; Thitiwat Sriprasart; Rujipat Samransamruajkit; Somkanya Tungsanga; Kanitha Tiankanon; Nuttha Lumlertgul; Asada Leelahavanichkul; Tueboon Sriphojanart; Terapong Tantawichien; Usa Thisyakorn; Chintana Chirathaworn; Kearkiat Praditpornsilpa; Kriang Tungsanga; Somchai Eiam-Ong; Visith Sitprija; John A Kellum; Nattachai Srisawat
Journal:  Intensive Care Med Exp       Date:  2020-12-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.